M10 Renal Flashcards
A patient with liver failure is most likely to have low levels of:
A)ammonia
B)creatnine
C)BUN
D)chlorine
Answer: C) BUN
BUN is made in the liver, therefore a patient with liver failure will not efficiently make BUN.
You notice in a patient’s chart that they’ve been diagnosed with BPH. Of the following, the patient most likely has what type of renal failure?
A)pre-renal
B)renal
C)post-renal
D)acute tubular necrosis
Answer: C) post renal failure
You are trying to determine what type of renal failure your patient has. You order urine studies and find a sodium of 15 meq/L and a high specific gravity of 1.025. The patient most likely has:
A)pre-renal failure
B)intra-renal failure
C)post-renal failure
Answer: A) pre-renal failure
The kidneys sense a low GFR and believe that volumes are low in the body, so they attempt to conserve Na+. By reabsorbing Na+ from the filtrate back into the blood, H20 will follow and it will inflate the blood volume. Additionally this movement of water and Na+ back into the blood will create a concentrated urine.
Which of the following medications is NOT typically a cause of intrinsic renal failure?
A)NSAIDS
B)beta blockers
C)ACE inhibitors
D)aminoglycosides
Answer: B) beta blockers
What type of relationship do phosphorus and calcium have?
Answer: inverse
Note: increased serum Ca+ will cause phosphate levels to drop
What will the parathyroid do if Ca+ levels are low?
Answer: PTH will be released
Note: once PTH released the kidney will activate vitamin D, and will produce more vitamin D which is needed to increased the absorption/retention of Ca+
What perentage decrease in GFR is required in order for calcium and phosphorus homeostasis to be altered?
A)10%
B)15%
C)20%
D)25%
Answer: D) 25%
Which is not a cause of hypocalcemia r/t kidney issues?
A)decreased renal synthesis of calcitriol
B)increased renal phosphate elimination
C)decreased levels of calcitonin
D)decreased intestinal Ca+ absorption
E)none of the above
Answer: B and C
Choice B)increased renal phosphate elimination is incorrect because that would help to increase Ca+ (they have an inverse relationship)
Choice C)decreased levels of calcitonin is incorrect because calcitonin has the opposite effect of PTH and will decrease calcium
The other answer choices are true of hypocalcemia.
What is true about hypocalcemia?
A)decreased serum phosphate will cause hypocalcemia
B)hypocalcemia will decrease PTH activation
C)enhanced renal secretion of phosphate will decrease calcium
D)hypocalcemia can lead to osteodystrophy
Answer: D) hypocalcemia can lead to osteodystrophy
Note: Increased phosphate (due to reduced renal elimination) will decrease calcium. Hypocalcemia will cause the parathyroid to be activated and release PTH to mobilize Ca+ from the bone and to create activated vitamin D in the kidney.
Which is not true about secondary hyperparathyroidism?
A)Decreased serum Ca+ will stimulate the parathyroid
B)PTH will be released
C)Ca+ will be mobilized from sarcoplasmic reticulum
D)Activated vitamin D will be created by kidney
Answer: C) Ca+ will be mobilized from sarcoplasmic reticulum
In secondary hyperparathyroidism, the low calcium will cause the parathyroid gland to release PTH to mobilize calcium. Calcium can be mobilized from bone, and the PTH stimulation will work to create activated vitamin D in the kidney to help with kidney absorption in the GI.
What issues compound secondary hyperparathyroidism in kidney failure?
A)decreased GFR
B)worsening of hyperphosphatemia
C)worsening of hypocalcemia
D)bone dissolution
Answer: All of the above.
If kidney failure is occurring, the GFR is decreased and thus phosphorous is accumulating. An elevated phosphorous level will cause a decrease in calcium. Calcium is low due to decreased renal synthesis of D3 and elevated retention of phosphorus. Even when calcium is mobilized from the bone, the phosphorus can continue to be elevated leading to tertiary hyperparathyroidism.
What hormone will be released if hypercalcemia is present?
A)calcitonin
B)calcitriol
Answer: A) calcitonin
Calcitonin has the opposite effect of PTH and will decrease Ca+ when it is elevated.
Calcitriol is activated vitamin D3.
Which is not a function of the kidney?
A)eliminate waste
B)secrete erythropoietin
C)regulate glucose
D)convert amino acids into glucose
E)activate vitamin D
Answer: none of the above.
All the choices listed are functions of the kidney.
Functions include eliminating waste, water balance, acid-base balance, BP, secreting erythropoietin, activating vitamin D, glucose regulation (including taking amino acids and converting into glucose, reabsorbing glucose from glomerular filtrate, and uptake of glucose from circulation).
Which of the following is not a function of the kidney?
A)Uptake of glucose from circulation
B)secrete erythropoietin
C)Activate vitamin D3
D)convert fats into glucose
E)one or more of the above
Answer D) converting fats into glucose
The kidney will convert amino acids into glucose.
Functions include eliminating waste, water balance, acid-base balance, BP, secreting erythropoietin, activating vitamin D, glucose regulation (including taking amino acids and converting into glucose, reabsorbing glucose from glomerular filtrate, and uptake of glucose from circulation).
What pore/transporter/mechanism is used to absorb filtered glucose in the kidney tubules?
Sodium-glucose cotransporter 2 (SGLT2)
The SGLT2 is used in the proximal tubule to absorb filtered glucose, but when serum levels exceed 180 then transporters are saturated and the excess glucose goes into urine to be eliminated from the body.
What is the mechanism of action for SGLT2 drugs?
A)It increases the amount of glucose reabsorbed into blood
B)It works on the ascending LOH
C)It is contraindicated in diabetics
D)None of the above
Answer D) none of the above
Drug class SGLT2 will target the sodium-glucose transporter found in the proximal tubule which absorbs filtered glucose. The drug will target the protein and allow glucose to spill into urine which will decrease the serum glucose. This drug is helpful in those with diabetes.
A) renal capsule (encloses kidney)
B)renal cortex (houses proximal and distal tubules)
C)renal pyramid (houses secreteing/collecting tubules and LOH). It’s a very “salty” area which creates a gradient.
D)renal artery
E)renal pelvis (renal calyces merge to create renal pelvis)
F)renal vein
G)ureter
What does the renal fascia do?
A)encloses kidney
B)attaches kidney to abdominal wall
C)structures the cortex of the kidney to filter urine
D)acts as a convergence for renal vasculature and ureter on the medial side of the kidney
Answer: B) attaches kidney to abdominal wall
The renal fascia is a fatty layer which helps attach the kidney to the abdominal wall.
Which structure of the kidney encases the glomerulus and collects urine?
A)arterioles
B)Bowman’s capsule
C)vasa recta
D)proximal tubule
Answer: B) Bowman’s capsule
What epithelial structure wraps the glomerular capillaries and provide a site for blood to be filtered through?
A)juxtaglomerular cells
B)macula dense cells
C)mesangial cells
D)podocytes
Answer: D) podocytes
Podocytes are part of Bowman’s capsule and are epithelial cells which wrap around the capillaries of the glomeruli. They are long foot projections which secure the capsule to the vasculature, and provide slits between the projects where blood is filtered through.
Which substance is not reabsorbed in the proximal tubule area?
A)Na+
B)Cl+
C)amino acids
D)K+
E)H+
Answer: E) H+
Substances reabsorbed in the proximal tubule are: glucose, A.A., Na, Cl, K, Phosphate, H20
Note: if glucose exceeds 180 it will exceed the threshold and will be excreted into urine.
In the kidneys what is the threshold for serum glucose, where any excess will be eliminated in urine?
180 mg/dL
PTH stimulation will ________ (increase/decrease) phosphate, and will _______ (increase/decrease) calcium.
PTH stimulation will decrease** phosphate via elimination in urine, and will **increase calcium via enhance reabsorption and other processes.
Which of the kidney tubules is permable only to water?
A)distal convoluted tubule
B)ascending LOH
C)descending LOH
D)collecting duct
Answer: C) descending LOH
Water will leave the tubule in the LOH creating concentrated urine.
Note: Na+ and Cl- can passively flow here but it is not significant.
Where can water not be absorbed within the kidney tubule system?
A)distal convoluted tubule
B)ascending LOH
C)descending LOH
D)collecting duct
Answer: A)distal convoluted tubule and B) ascending LOH
In the distal convoluted tubule, there is active reabsorption of Na+ but no water reabsorption.
In the ascending LOH, there is active reabsorption (movement of ions out of tubule) of Na, K, Cl, Mg, Ca. No water is reabsorbed here, thus the urine is dilute.
What ion movement occurs at the collecting tubule area?
A)Mg
B)Na+/K+H+
C)Na+/K+
D)K+/Cl-
Answer: B) Na+/K+H+
Na+ is reabsorbed in exchange for K+ and H+. This area is regulated by aldosterone (which will increase Na+ and H20 reabsorption and enhance K+ secretion).
ADH can act here as well (H20 will be reabsorbed=concentrated urine).
If the diameter of the afferent arteriole increases, then the GFR will ______. If the diameter of the afferent arteriole decreases, then the GFR will _______.
If the diameter of the afferent arteriole increases, then the GFR will increase. If the diameter of the afferent arteriole decreases, then the GFR will decrease.
If the diameter of the efferent arteriole increases, then the GFR will ______. If the diameter of the efferent arteriole decreases, then the GFR will _______.
If the diameter of the efferent arteriole increases, then the GFR will decrease. If the diameter of the efferent arteriole decreases, then the GFR will increase.
What area of the cortex does the distal tubule pass between the afferent and efferent arterioles?
Juxtaglomerular apparatus (JGA)
Which cells in the JGA release renin?
A)macula densa
B)juxtaglomerular
C)mesangial
D)none of the above
Answer: B)juxtaglomerular cells
These cells release renin to help increase GFR when needed. The renin will increase Na+ reabsorption and also release angiotensin II which causes vasoconstriction of the efferent arteriole (causes increased GFR).
Which cells in the JGA sense Na levels?
A)macula densa
B)juxtaglomerular
C)mesangial
D)Na/K+H+ transporter
Answer: A) macula densa
Macula densa cells sense changes in Na and help regulate GFR. If blood pressure is low, they will help adenosine to be released which causes vasoconstriction of afferent arteriole (which will decrease GFR).
If blood pressure is low, the _______ cells will help _______ to be released which will _________ the _________ arteriole and cause the GFR to _________.
A)mesangial, renin, vasoconstrict, efferent, increase
B)macula densa, adenosine, vasoconstrict, afferent, decrease
C)juxtaglomerular, renin, vasodilate, efferent, decrease
D)none of the above
Answer: B
If blood pressure is low, the macula densa cells will help adenosine** to be released which will **vasoconstrict the afferent arteriole and cause the GFR to decrease.
Match the following cells and functions:
A) macula densa: renin; juxtaglomerular: natriuretic factor/angiotensin II; mesangial: adenosine
B)macula densa:adenosine; juxtaglomerular: renin; mesangial: natriuretic factor/angiotensin II
C) macula densa:renin; juxtaglomerular: adenosine; mesangial: natriuretic factor/angiotensin II
D)none of the above
Answer B
Macula densa in response to low BP will help to have adenosine released leading to vasoconstriction of afferent arteriole.
Juxtaglomerular: in response to low BP will release renin which increases Na+ reabsorption and releases angiotensin II so vasoconstriction of efferent arteriole.
Mesangial: has receptors for natriuretic factor and angiotensin II. The natriuretic stimulation will cause vasodilation in afferent arteriole.
What is not true of mesangial cells of the JGA?
A)they act as macrophages
B)can contract to regulate blood flow
C)have receptors for natriuretic factor and aldosterone
D)Natriuretic stimulation will cause vasodilation of the afferent arterioles
Answer C) have receptors for natriuretic factor and aldosterone
Mesangial cells have receptors for natriuretic factor and angiotensin II